Chemoinformaics analysis of Oxydihydroartocarpesin
| Molecular Weight | 370.357 | nRot | 3 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 19 |
| Exact Molecular Weight | 370.105 | nRing | 3 |
| Solubility: LogS | -3.387 | nHRing | 1 |
| Solubility: LogP | 3.786 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 51.0163 |
| nHD | 5 | BPOL | 20.6617 |
| QED | 0.479 |
| Synth | 3.111 |
| Natural Product Likeliness | 1.867 |
| NR-PPAR-gamma | 0.97 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.587 |
| HIA | 0.033 |
| CACO-2 | -4.951 |
| MDCK | 0.0000138 |
| BBB | 0.004 |
| PPB | 0.980815 |
| VDSS | 0.456 |
| FU | 0.0509686 |
| CYP1A2-inh | 0.934 |
| CYP1A2-sub | 0.284 |
| CYP2c19-inh | 0.175 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.821 |
| CYP2c9-sub | 0.895 |
| CYP2d6-inh | 0.687 |
| CYP2d6-sub | 0.244 |
| CYP3a4-inh | 0.636 |
| CYP3a4-sub | 0.099 |
| CL | 4.989 |
| T12 | 0.831 |
| hERG | 0.073 |
| Ames | 0.336 |
| ROA | 0.025 |
| SkinSen | 0.932 |
| Carcinogencity | 0.332 |
| EI | 0.893 |
| Respiratory | 0.168 |
| NR-Aromatase | 0.913 |
| Antiviral | Yes |
| Prediction | 0.897808 |